Cardio-Protective Effect of Hunteria umbellata Seed: Experimental and In-silico Approaches doi.org/10.26538/tjnpr/v6i1.16

Main Article Content

Adetoun E. Morakinyo
Femi E. Omoniyi
Samuel C. Nzekwe
Abel K. Oyebamiji
Joy M. Adelowo
Sulaiman A. Lawal
Angel A. Olumade
Elijah O. Olopade
Temitope A. Oyedepo

Abstract

Cardiotixicity is one of the main causes related to sudden death in the world. The study investigated the ameliorative potential of Hunteria umbellata against isoproterenol (ISO)- induced cardiotoxicity using experimental and in-silico approaches. The ethanol extract of H. umbellata was prepared, phytochemically screened and quantified. In vitro antioxidant potential of the extract was also carried out. Male Wistar rats (30) were randomly and equally grouped into five and used for this study. After administration of the extract, the rats were sacrificed. Thereafter, the cardiac toxicity biomarkers (CK-MB, LDH, AST) and lipid profiles [Triglycerides (TG), Total cholesterol (TC) and High-density cholesterol (HDL-c)] were estimated from the blood plasma. Five molecular compounds from H. umbellata seed were selected based on their percentage yield and they were subjected to optimization using Spartan The optimized compounds were docked against β1-adrenergic receptor (PDB ID: 2ycw). Data obtained was analyzed using standard descriptive and inferential statistics. Pre-treatment with the extract caused a significant decrease in the levels LDH, AST, TC and TG with the most apparent effect at 100 mg/kg bwt. There was no significant difference in the activity of CK-MB. It was observed that compound (A), (C) and (E) inhibited β1-adrenergic receptor than the referenced drug. In conclusion, H. umbellata exhibited ameliorative effects against ISO-induced myocardial damage, suggesting preliminary anti-dyslipidemia abilities possibly due to high phenolic and flavonoid contents. 

Article Details

How to Cite
E. Morakinyo, A., E. Omoniyi, F., C. Nzekwe, S., K. Oyebamiji, A., M. Adelowo, J., A. Lawal, S., A. Olumade, A., O. Olopade, E., & A. Oyedepo, T. (2022). Cardio-Protective Effect of Hunteria umbellata Seed: Experimental and In-silico Approaches: doi.org/10.26538/tjnpr/v6i1.16. Tropical Journal of Natural Product Research (TJNPR), 6(1), :87-94. https://tjnpr.org/index.php/home/article/view/200
Section
Articles

References

Shirish SP, Naikwade NS, Shikalgar TS. The cardioprotective effect of Argemone mexicana on isoproterenol induced cardiac toxicity in rats. Eur J Pharm Med Res. 2018; 5(6):367-375.

Peiris D, Ghosh A, Manne-Goehler J, Jaacks LM, Theilmann M, Marcus ME, Zhumadilov Z, Tsabedze L, Supiyev A, Silver BK, Sibai AM, Norov B, Mayige MT, Martins JS, Lunet N, Labadarios D, Jorgensen JMA, Houehanou C, Guwatudde D, Gurung MS, Damasceno A, Aryal KK, Andall-Brereton G, Agoudavi K, McKenzie B, Webster J, Atun R, Bärnighausen T, Vollmer S, Davies JI, Geldsetzer P. Cardiovascular disease risk profile and management practices in 45 low-income and middleincome countries: A cross-sectional study of nationally representative individual-level survey data. PLoS Med.2021; 18(3):e1003485.

Okoro TE and Jumbo J. Cardiovascular event risk estimation among residents of a rural setting in Bayelsa state, Nigeria. Am J Cardiovasc Dis. 2021; 11(3):300-315.

Ike SO and Onyema CT. Cardiovascular diseases in Nigeria: What has happened in the past 20 years? Nig J Cardiol. 2020; 17(1):21-26.

Hajar R. Risk Factors for Coronary Artery Disease: Historical Perspectives. Heart views; 2017; 18(3):109-114.

Brown JC, Gerhardt TE, Kwon E. Risk Factors for Coronary Artery Disease. Treasure Island (FL): StatPearls Publishing; 2021. PMID:32119297.

Ajayi AM, Ologe MO, Chidiebere E, Ilerioluwa EO, Ademowo OA. Antinociceptive Activity of Flavonoid-Rich Ethylacetate Fraction ofOcimum GratissimumL. Leaves in Mice. Trop J Nat Prod Res. 2021; 5(6):1088-1093.

Newman DJ and Cragg GM. Natural products as sources ofnew drugs over the 30 years from 1981 to 2014. J Nat Prod.2016; 79(3):629-661.

Fadahunsi OS, Adegbola PI, Olorunnisola OS, Subair TI, Adepoju DO, Abijo AZ. Ethno-medicinal, phytochemistry, and pharmacological importance of Hunteria umbellate (K. Schum.) Hallier f. (Apocynaceae): a useful medicinal plant of sub-Saharan Africa. Clin Phytosci. 2021; 7(54):1-17.

Oboh G, Adebayo AA, Ademosun AO. Erectionstimulating, anti-diabetic and antioxidant properties of Hunteria umbellata and Cylicodiscus gabunensis water extractable phytochemicals. J Compl Integr Med. 2017; 15(1):1-11.

Falodun A, Nworgu Z, Ikponmwonsa MO. Phytochemical components of Hunteria umbellata (K. Schum) and its effect on isolated non-pregnant rat uterus in oestrus. Pak J Pharm Sci. 2006; 19(3):256-258.

Oboh G, Adebayo AA, Ademosun AO, Boligon AA. In vitro inhibition of phosphodiesterase-5 and arginase activities from rat penile tissue by two Nigerian herbs (Hunteria umbellate and Anogeissus leiocarpus). J Basic Clin Physiol Pharmacol. 2017a; 28(4):393-401.

Ajibola OOE, Akinmegha TS, Nwaiwu O, Balogun OJ. Biometric Analysis of Hunteria umbellata (K.Schum.) Hallier f and Metformin in the treatment of diabetes. J Appl Sci Environ Manage. 2018; 22(4):561-564.

Adeneye AA, Adeyemi OO, Agbaje EO, Banjo AA. Evaluation of the toxicity and reversibility profile of the aqueous seed extract of Hunteria umbellata (K. Schum.) Hallier f. in rodents. Afr J Trad Compl Altern Med. 2010; 7(4):350–369.

Trease GE and Evans WC. A test book of pharmacognosy, (15thedition). Elsevier Company, Philadelphia, USA. 2002.191-148p.

Sofowora EA. Medicinal and Traditional Medicine in Africa, (3rdedition). Ibadan: Spectrum book Ltd: 2008; 89-133 p.

Singleton VL, Orthofer R, Lamuela-Raventos RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Am J Enol. 1999; 299(1):152-178.

Sun PX, Yie LK, Zhang ZL, Hu M, Lu L. Colometric determination of the total content of the flavonoids in epimedium capsules. J Shenyang Pharm Univ. 1999; 16(1):68-70.

Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LebensmWiss u-Technol. 1995; 28(1):25-30.

Benzie IF and Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of ‘‘antioxidant power’’: The FRAP Assay. Anal Biochem. 1996; 239(1):70-76.

Richmond W. Cholesterol enzymatic colorimetric test chopPAP method of estimation of total cholesterol in serum. Clin Chem. 1973; 191(1):1350-1356.

Tietz NW. Clinical Guide to Laboratory Tests. (2nd ed). W.B. Philadelphia, PA. USA: Saunders Company; 1990; 554–556p.

Gidez LL, Miller GJ, Burstein M, Eder HA. Analysis of plasma high density lipoprotein subclasses by a precipitation procedure: correlation with preparative and analytical ultracentrifugation. In Report of the High-Density Lipoprotein Methodology Workshop. K. Lippel, editor. DHEW (NIH) Publication No. 79-1661. 1979 1(1); 328-335.

Reitman S and Frankel S. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am J Clin Pathol. 1957; 28(1):56-63.

Schmidt E, Schmidt FW. Determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Enzyme Biol Clin. 1963; 3(1):1-5.

Akinlusi I, Akinpelu BA, Morakinyo AE, Adeleke AM, Oyedepo TA, Oyedapo OO. Cardioprotective Potentials of Aqueous Extract of Chrysophyllum Albidum (G. DonHoll.) Pulp on Isoproterenol-Induced cardiotoxicity in Wistar Rats. Am J Cardiovasc Dis Res. 2019; 6(1):15-22.

Ganiyu O, Adeniyi AA, Ayokunle OA, Oluwaseun AA. Aphrodisiac effect of Hunteria umbellata seed extract: Modulation of nitric oxide level and arginase activity in vivo. Pathophysiol. 2019; 26(1):39-47.

Moukhametzianov R, Warne T, Edwards PC, Serrano-Vega MJ, Leslie AGW, Tate CG, Schertler GFX. Two distinct conformations of helix 6 observed in antagonist-bound structures of a β1-adrenergic receptor. Proc Natl Acad Sci2011; 108(20):8228-8232.

Tungmunnithum D, Thongboonyou A, Pholboon A, Yangsabai A. Flavonoids and Other Phenolic Compounds from Medicinal Plants for Pharmaceutical and Medical Aspects: An Overview. J Med. 2018; 5(3):93.

Najjar RS and Feresin RG. Protective Role of Polyphenols inHeart Failure: Molecular Targets and Cellular Mechanisms Underlying Their Therapeutic Potential. Int JMol Sci. 2021; 22(4):1668.

Pandey KB and Rizvi SI. Ferric Reducing and Radical Scavenging Activities of Selected Important Polyphenols Present in Foods. Int J Food Prop. 2012; 15(3):702–708.

Garcia E, Bennett DW, Connelly MA, Jeyarajah EJ, Warf FC, Shalaurova I, Matyus SP, Wolak-Dinsmore J, Oskardmay DN, Young RM, Sampson M, Remaley AT,Otvos JD. The extended lipid panel assay: a clinicallydeployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B. Lipids Health Dis. 2020; 19(1):247.

Elhemely MA, Omar HA, Ain-Shoka AA, Abd El-Latif HA, Abo-youssef AM, El Sherbiny GA. Rosuvastatin and ellagic acid protect against isoproterenol-induced myocardial infarction in hyperlipidemic rats. Beni-seuf Univ J Appl Sci. 2014; 3(4):239-246.

Dhivya V, Priya LB, Chirayil HT, Sathiskumar S, Huang CY, Padma VV. Piperine modulates isoproterenol induced myocardial ischemia through antioxidant and antidyslipidemic effect in male Wistar rats. Biomed Pharmacother. 2017; 87(1):705-713.

Morakinyo AE, Oladeji OA, Fajobi AO, Adelowo JM, Babarinde SO, Adepoju AE. (2020). Phytochemical Analysis and Anti-Hyperlipidemic Potential of Ethanolic Extract of Hunteria umbellata Seed. IOSR J Pharm Biol Sci. 2020; 15(4):01-09.

Adeneye AA and Crooks PA. Weight losing, antihyperlipidemic and cardioprotective effects of the alkaloid fraction of Hunteria umbellata seed extract on normal and triton-induced hyperlipidemic rats. Asian Pac JTrop Biomed. 2015; 5(5):387-394.

Oyebamiji AK and Semire B. In-Silico Study on Anti-bacteria and Anti-fungal Activities of 3,4-Dihydropyrimidin-2(1H)-One Urea Derivatives. Chem Afr. 2021; 4(1):149-159

Akintelu SA, Folorunso AS, Oyebamiji AK. Phytochemical and antibacterial investigation of Moringa oleifera seed: experimental and computational approaches. Ecletica Quim J. 2021; 46(2):17-25.